Skip to main content

Lazanda FDA Approval History

FDA Approved: Yes (First approved June 30, 2011)
Brand name: Lazanda
Generic name: fentanyl
Dosage form: Nasal Spray
Previous Name: NasalFent
Company: Archimedes Pharma
Treatment for: Pain

Lazanda (fentanyl) is an opioid analgesic nasal spray for the management of breakthrough pain in cancer patients.

Development timeline for Lazanda

Jun 30, 2011Approval FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
Sep  7, 2009Archimedes Announces US Filing of NasalFent for the treatment of Breakthrough Cancer Pain

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.